Washington, DC - Tomorrow at 10:00am Eastern Time in HVC-210, the Select Investigative Panel on Infant Lives will hold a hearing to examine The Pricing of Fetal Tissue, and whether abortion clinics and middleman businesses were making a profit from the transfer of human fetal tissue - a violation of federal law.
Pursuant to H. Res. 461, the Select Investigative Panel has subpoenaed the business and accounting documents of several organizations to determine if they were in violation of 42 USC § 289g-2, which prohibits the transfer of any fetal tissue for valuable consideration. The statute strictly limits payments to cover reasonable costs associated with tissue procurement.
“The release of those horrific videos last summer raised many questions about whether abortion clinics and middleman tissue procurement businesses were profiting from the sale of baby body parts, organs and tissues," Chairman Blackburn said. “This hearing will examine business documents, invoices, marketing brochures, and management documents that reveal one for-profit procurement business and several abortion clinics may have acted in violation of federal law by profiting from the sale of baby body parts, organs and tissues."
WHAT: Select Investigative Panel Hearing on The Pricing of Fetal Tissue
WHEN: 10:00am ET on Wednesday, April 20, 2016
WHERE: HVC-210, United States Capitol
WITNESSES:
* U.S. Senator Ben Sasse (R-NE)
* U.S. Senator Jeanne Shaheen (D-NH)
* Fay Clayton - Robinson Curley & Clayton, P.C.
* Catherine Glenn Foster - Charlotte Lozier Institute, Sound Legal
* Brian Lennon - Warner Norcross & Judd
* Michael Norton - Thomas N. Scheffel & Associates, P.C.
* Robert Raben - President and Founder, The Raben Group
* Kenneth Sukhia - Sukhia Law Group
The Majority Memorandum, a White Paper on The Pricing of Fetal Tissue, Majority Exhibits, a witness list and testimony are available HERE. A live webcast of the hearing will also be available at the same link.
